miscsubjectsAI governance
Evidence review

PT-141 for Trigeminal: Evidence Review

· · 2 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-trigeminal`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-trigeminal

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-trigeminal/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-trigeminal/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-trigeminal/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-trigeminal/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.17 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Melanocortin Receptors, Melanotropic Peptides and Penile Erection (source s1)

Describes PT-141 central melanocortin action for sexual response.

Evidence type: Published research.

Bremelanotide (subcutaneous route) (source s2)

Approved use limited to HSDD; no trigeminal mention.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Trigeminal neuralgia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedPT-141: Brain-Level Arousal · 17 humanPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood… · 8 humanPT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathw… · 3 humanPT-141 for Diabetic Neuropathy: Evidence-Graded Review · 3 human
Evidence · 3 sources · swipe →chain 32e645dc3950 · verify chain · provenance
1 / 3
Evidence ledger 3 · tier-ranked · API
mechanistic
PT-141 (bremelanotide) is a melanocortin receptor agonist acting primarily on MC4R in the CNS to influence arousal pathways.
sources: s1
humanlow confidence
No human clinical trials examine PT-141 for trigeminal neuralgia or related conditions.
sources: s2
mechanisticlow confidence
Intranasal delivery of melanocortin peptides like PT-141 can involve trigeminal nerve pathways to reach the CNS.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:05
PT-141 for Trigeminal: Evidence Review · 3 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Trigeminal
Slug: pt-141-trigeminal
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative
it output
{
  "slug": "pt-141-trigeminal",
  "title": "PT-141 for Trigeminal: Evidence Review",
  "body": "## What's breaking down\n\nTrigeminal issues often involve degeneration in the trigeminal nerve or its central processing pathways. This can include nerve fiber damage, inflammation around the nerve root, or changes in how the brain handles signals from the face. When breakdown outruns repair, pain or altered sensation can persist. The provided peptide chain focuses on a sexual / CNS arousal layer rather than direct nerve repair.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist primarily on MC4R in the central nervous system. This central action is tied to arousal pathways in the hypothalamus. If CNS arousal components overlap with your trigeminal presentation, the discussion centers on potential tissue-level effects rather than symptom suppression alone.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nNo human trials link PT-141 directly to trigeminal conditions (preclinical tier absent; human tie
8dd9f01b7bcc94f4
Machine verification: /api/articles/pt-141-trigeminal/contributions

Related articles

Trigeminal neuralgia · condition map

Open evidence map →
PT-141: Brain-Level Arousalpt-141PT-141 and Benzodiazepine Withdrawal: A Data-First Evidence Reviewpt-141-benzo-withdrawalPT-141 and Benzodiazepines: Evidence Review on CNS Arousal Layerspt-141-benzodiazepinesPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood…pt-141-blood-pressure-medsPT-141 for Statin-Associated Cognitive Effects: Evidence Reviewpt-141-brain-fogPT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Reviewpt-141-carpal-tunnel
Ask this article · 5 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "PT-141 (bremelanotide) is a melanocortin receptor agonist acting primarily on MC4R in the CNS to influence arousal pathways."?
ask pt-141-trigeminal claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No human clinical trials examine PT-141 for trigeminal neuralgia or related conditions."?
ask pt-141-trigeminal claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Intranasal delivery of melanocortin peptides like PT-141 can involve trigeminal nerve pathways to reach the CNS."?
ask pt-141-trigeminal claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for Trigeminal: Evidence Review — and what would you need me to tell you first?
ask pt-141-trigeminal condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for Trigeminal: Evidence Review (studies vs anecdotes)?
ask pt-141-trigeminal good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…